Johnson & JohnsonJohnson & JohnsonJohnson & Johnson

Johnson & Johnson

No trades
See on Supercharts

What's happening today with Johnson & Johnson

  • Johnson & Johnson raised its quarterly dividend by 4.2% to $1.24 per share, marking 62 years of growth. New yield is 3.36%, payable on June 4 to shareholders recorded by May 21.
  • Johnson & Johnson delayed U.S. biosimilar Stelara launch to 2025 with Alvotech, boosting its 2024-2025 revenue. Alvotech will launch in Japan, Canada, Europe this year.
  • Johnson & Johnson's Q1 earnings were $2.71 per share, beating forecasts. Sales hit $21.38 billion, just under predictions. FY EPS forecast is $10.57-$10.72. Darzalex sales rose 19% to $2.69 billion.
What else is happeningWhat else is happening
Market capitalization
‪355.51 B‬USD
‪14.17 B‬USD
‪85.15 B‬USD
‪2.40 B‬
Beta (1Y)
0.57

About Johnson & Johnson

CEO
Joaquin Duato
Headquarters
New Brunswick
Website
Employees (FY)
‪131.9 K‬
Founded
1887
ISIN
US4781601046
FIGI
BBG000BMHYD1
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of JNJ is 144.45 USD — it has decreased by 2.13% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Johnson & Johnson stocks are traded under the ticker JNJ.
Johnson & Johnson is going to release the next earnings report on Jul 16, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Johnson & Johnson has a max estimate of 215.00 USD and a min estimate of 160.00 USD.
JNJ earnings for the last quarter are 2.29 USD whereas the estimation was 2.28 USD which accounts for 0.40% surprise. Estimated earnings for the next quarter are 2.64 USD. See more details about Johnson & Johnson earnings.
Johnson & Johnson revenue for the last quarter amounts to ‪21.40 B‬ USD despite the estimated figure of ‪21.02 B‬ USD. In the next quarter revenue is expected to reach ‪21.39 B‬ USD.
Yes, you can track Johnson & Johnson financials in yearly and quarterly reports right on TradingView.
Like other stocks, JNJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Johnson & Johnson stock right from TradingView charts — choose your broker and connect to your account.
JNJ reached its all-time high on Apr 25, 2022 with the price of 186.69 USD, and its all-time low was 0.52 USD and was reached on Mar 14, 1968.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪131.90 K‬ employees. See our rating of the largest employees — is Johnson & Johnson on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Johnson & Johnson EBITDA is ‪31.36 B‬ USD, and current EBITDA margin is 34.82%. See more stats in Johnson & Johnson financial statements.